Highlights WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Market Closed - OTC Markets Other stock markets 15:46:15 2024-05-28 EDT			5-day change	1st Jan Change
2.946 ^USD	-6.77%		-11.66%	-60.46%

05-27	China stocks rise as industrial profits grow; energy, semiconductor shares lead gains	RE
05-17	Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

China stocks rise as industrial profits grow; energy, semiconductor shares lead gains	05-27	RE
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%	05-17	MT
US Congress Drafts Bill Asking Drug Firms to Unlink from Chinese Biotech Firms	05-14	MT
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling	05-13	DJ
Pacific Assets Trust cautiously optimistic after outpacing benchmark	04-30	AN
WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump	03-27	MT
WuXi Biologics 2023 Net Profit Fell on Higher Expenses, Impairment Losses	03-26	DJ
WuXi Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
WuXi AppTec's Shares Fall After Downbeat Guidance	03-19	DJ
WuXi AppTec's Net Profit Jumps, Reiterates It Doesn't Pose Security Threat	03-18	DJ
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares	03-14	RE
Biotech trade association to split with China's WuXi AppTec	03-13	RE
WuXi Companies' Shares Rise on Receding Worries About Potential U.S. Sanctions	03-04	DJ
Wuxi Biologics Says It Is Not a Wuxi AppTec Subsidiary Amid US Security Risk Probe	02-13	MT
WuXi Companies' Shares Slide Amid Concerns Over Proposed U.S. Bill	02-02	DJ
WuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland	01-31	CI
WuXi Biologics Launches WuXia ADCC PLUS? for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect	01-24	CI
WuXi Biologics Receives U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody?	01-16	CI
Wuxi Biologics Shares Rise After Jump in December Projects	01-11	DJ
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates	01-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Highlights

Filters